Article
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy.
Oncotarget - 20 Sept 2016
Lu Ming-Ying, Huang Ching-I, Hsieh Ming-Yen, Hsieh Tusty-Juan, Hsi Edward, Tsai Pei-Chien, Tsai Yi-Shan, Lin Ching-Chih, Hsieh Meng-Hsuan, Liang Po-Cheng, Lin Yi-Hung, Hou Nai-Jen, Yeh Ming-Lun, Huang Chung-Feng, Lin Zu-Yau, Chen Shinn-Cherng, Huang Jee-Fu, Chuang Wan-Long, Dai Chia-Yen, Yu Ming-Lung
Abstract excerpt
Hepatitis C virus (HCV) can replicate in peripheral blood mononuclear cells (PBMCs), which can produce interferon to defend against virus infection. We hypothesized that dynamic gene expression in PBMCs might impact the treatment efficacy of peginterferon/ribavirin in HCV patients. PBMCs were collected at baseline, 1st week and 4th week of treatment from 27 chronic HCV-1 patients with 48-week...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
